These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29163784)

  • 1. IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
    Kessler SM; Lederer E; Laggai S; Golob-Schwarzl N; Hosseini K; Petzold J; Schweiger C; Reihs R; Keil M; Hoffmann J; Mayr C; Kiesslich T; Pichler M; Kim KS; Rhee H; Park YN; Lax S; Obrist P; Kiemer AK; Haybaeck J
    Oncotarget; 2017 Oct; 8(52):89736-89745. PubMed ID: 29163784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.
    Hammer NA; Hansen Tv; Byskov AG; Rajpert-De Meyts E; Grøndahl ML; Bredkjaer HE; Wewer UM; Christiansen J; Nielsen FC
    Reproduction; 2005 Aug; 130(2):203-12. PubMed ID: 16049158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
    Dahlem C; Barghash A; Puchas P; Haybaeck J; Kessler SM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.
    Kessler SM; Laggai S; Barghash A; Schultheiss CS; Lederer E; Artl M; Helms V; Haybaeck J; Kiemer AK
    Cell Death Dis; 2015 Oct; 6(10):e1894. PubMed ID: 26426686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma.
    Barghash A; Golob-Schwarzl N; Helms V; Haybaeck J; Kessler SM
    Oncotarget; 2016 Aug; 7(31):49743-49750. PubMed ID: 27391348
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Czepukojc B; Abuhaliema A; Barghash A; Tierling S; Naß N; Simon Y; Körbel C; Cadenas C; van Hul N; Sachinidis A; Hengstler JG; Helms V; Laschke MW; Walter J; Haybaeck J; Leclercq I; Kiemer AK; Kessler SM
    Front Med (Lausanne); 2019; 6():179. PubMed ID: 31555647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncofetal protein IMP3, a new cancer biomarker.
    Gong Y; Woda BA; Jiang Z
    Adv Anat Pathol; 2014 May; 21(3):191-200. PubMed ID: 24713990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer.
    Di Fusco D; Di Grazia A; Di Maggio G; Segreto MT; Iannucci A; Maresca C; De Stefano A; Sica G; Stolfi C; Monteleone G; Monteleone I
    Cell Death Dis; 2023 Apr; 14(4):243. PubMed ID: 37024466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.
    Liu X; Ye H; Li L; Li W; Zhang Y; Zhang JY
    J Immunol Res; 2014; 2014():326593. PubMed ID: 24872956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.
    Li Y; Francia G; Zhang JY
    Oncotarget; 2015 Oct; 6(32):32656-68. PubMed ID: 26416451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p62/IMP2 can Promote Cell Migration in Hepatocellular Carcinoma via Activation of the Wnt/β-Catenin Pathway.
    Xing M; Li P; Wang X; Li J; Shi J; Qin J; Zhang X; Ma Y; Francia G; Zhang JY
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy.
    Dahlem C; Abuhaliema A; Kessler SM; Kröhler T; Zoller BGE; Chanda S; Wu Y; Both S; Müller F; Lepikhov K; Kirsch SH; Laggai S; Müller R; Empting M; Kiemer AK
    ACS Chem Biol; 2022 Feb; 17(2):361-375. PubMed ID: 35023719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.
    Szarvas T; vom Dorp F; Niedworok C; Melchior-Becker A; Fischer JW; Singer BB; Reis H; Bánkfalvi Á; Schmid KW; Romics I; Ergün S; Rübben H
    BJU Int; 2012 Sep; 110(6 Pt B):E308-17. PubMed ID: 22500655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma.
    Himoto T; Kuriyama S; Zhang JY; Chan EK; Nishioka M; Tan EM
    Int J Oncol; 2005 Feb; 26(2):311-7. PubMed ID: 15645114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
    Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
    Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
    Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
    Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target.
    Chanda S; Lepikhov K; Dahlem C; Schymik HS; Hoppstädter J; Geber AK; Wagner K; Kessler SM; Empting M; Kiemer AK
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):41. PubMed ID: 38287808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.
    Burdelski C; Jakani-Karimi N; Jacobsen F; Möller-Koop C; Minner S; Simon R; Sauter G; Steurer S; Clauditz TS; Wilczak W
    Oncol Rep; 2018 Jan; 39(1):3-12. PubMed ID: 29115542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.
    Lin L; Zhang J; Wang Y; Ju W; Ma Y; Li L; Chen L
    Oncol Lett; 2013 Sep; 6(3):740-744. PubMed ID: 24137402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.